ArticleHealth affairs scholar2026
Patterns and implications of 2025 NIH-F31 grant terminations for the predoctoral training pipeline.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In 2025, the National Institutes of Health (NIH) terminated student grants across the Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship mechanisms, including both general F31 and F31-Diversity awards, disrupting a critical training pipeline marked by inequities. Since the terminations, the status of many grants has shifted amid an evolving landscape of freezes, appeals, and reinstatements, leading to prolonged uncertainty for predoctoral trainees. Methods: In this article, we analyzed from publicly available data the scope and geographical distribution of terminated F31 (general and diversity) awards from 2025 and considered the implications of these terminations on trainees. We queried publicly available data from Grant Witness (November 16, 2025, to December 18, 2025), a website that monitors grant terminations across various US government agencies, such as NIH. Results: We found that 405 F31 grants were affected by the 2025 terminations; of these, 136 were general F31s, and 269 were F31-Diversity awards. States in the South and Midwest were disproportionately represented among the terminations of diversity-promoting F31s. Conclusion: Federal agencies and academic institutions may consider implementing safeguards, including protections against midyear grant terminations and emergency bridge funding to protect trainees during periods of political and funding instability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.